Analysis of ABC (D) stratification for screening patients with gastric cancer

Table 3 Summary of 10 patients with gastric cancer in group A and group A’

Case	Stratification	Age (yr)	Sex	Location	Macroscopic type	Differentiation	PG I/PG II levels (ng/mL)	PG I/PG II ratio	Endoscopic findings	PPI prescription	H. pylori eradication therapy
1	A	70	M	U	Borrmann II	Poor	28.5/7.3	3.9	Open type	No	No
2	A'	48	F	M	II c + III	Signet ring cell carcinoma	55.9/8.2	6.8	Closed type	No	Yes
3	A	68	M	M	II a + II c	Well	64.1/11.8	5.4	Open type	No	No
4	A	78	F	L	II c	Well	13.6/4.2	3.2	Open type	No	No
5	A'	67	F	L	II c	Well	46.4/10.8	4.3	Closed type	Yes	No
6	A'	79	F	M	II a + II c	Well	86.2/10.9	7.9	Closed type	Yes	No
7	A'	77	M	M	LST-G	Well	384.9/54.3	7.1	Non	Yes	No
8	A'	77	F	U	II c	Well	17.3/5.2	3.3	Open type	No	Yes
9	A'	57	M	M	II c	Well	36.9/6.8	5.4	Open type	No	Yes
10	A'	71	M	M	II a + II c	Well	38.6/7.9	4.9	Open type	No	Yes

H. pylori: Helicobacter pylori; PG: Pepsinogen; U: Upper thirds of the stomach; M: Middle; L: Lower; PPI: Proton pump inhibitor; Non: No atrophic change.